ClinicalTrialsFinder

Post Essential Thrombocythaemia Myelofibrosis (PET-MF) Clinical Trials in Hong Kong

1 recruitingHong Kong, Hong Kong

Showing 1–1 of 1 trials

Recruiting
Phase 2

Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis

Primary myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
The University of Hong Kong20 enrolled1 locationNCT06770842